WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a privately held regenerative medicine company, today announced the formation of its Scientific Advisory Board. Histogenics is advancing NeoCart®, an autologous bioengineered neocartilage grown outside the body using the patient’s own cells for the regeneration of cartilage lesions, and VeriCart™, a three-dimensional cartilage matrix to stimulate cartilage repair in a simple, one-step procedure.
